BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18627117)

  • 1. Celecoxib: new indication. Ankylosing spondylitis: no pain justifies the use of a cox-2 inhibitor. Patients still exposed to unjustified risks.
    Prescrire Int; 2008 Jun; 17(95):106. PubMed ID: 18627117
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study.
    Sieper J; Klopsch T; Richter M; Kapelle A; Rudwaleit M; Schwank S; Regourd E; May M
    Ann Rheum Dis; 2008 Mar; 67(3):323-9. PubMed ID: 17616556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing the risks and benefits of celecoxib.
    Caldwell B; Beasley R; Weatherall M; Metcalfe S
    Am J Med; 2007 Jun; 120(6):e17. PubMed ID: 17524734
    [No Abstract]   [Full Text] [Related]  

  • 4. The safety of celecoxib in ankylosing spondylitis treatment.
    Poddubnyy DA; Song IH; Sieper J
    Expert Opin Drug Saf; 2008 Jul; 7(4):401-9. PubMed ID: 18613804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib and cardiovascular risks.
    Brophy JM
    Expert Opin Drug Saf; 2005 Nov; 4(6):1005-15. PubMed ID: 16255660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COX-2 selective drugs and cardiovascular risks: same data but discrepant conclusions?
    Bannwarth B
    Expert Opin Drug Saf; 2006 Jan; 5(1):1-2; author reply 1-2. PubMed ID: 16370948
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of celecoxib, a cyclooxygenase-2 inhibitor, on the pathophysiology of adjuvant arthritis in rat.
    Noguchi M; Kimoto A; Kobayashi S; Yoshino T; Miyata K; Sasamata M
    Eur J Pharmacol; 2005 Apr; 513(3):229-35. PubMed ID: 15862805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celecoxib approved for pain relief for AS.
    Health News; 2005 Nov; 11(11):2. PubMed ID: 16294424
    [No Abstract]   [Full Text] [Related]  

  • 9. The pain game.
    Wadman M
    Nature; 2007 Jul; 448(7152):400-1. PubMed ID: 17653159
    [No Abstract]   [Full Text] [Related]  

  • 10. Arthritis medicines and cardiovascular events--"house of coxibs".
    Topol EJ
    JAMA; 2005 Jan; 293(3):366-8. PubMed ID: 15623849
    [No Abstract]   [Full Text] [Related]  

  • 11. The adenoma prevention with celecoxib and prevention of colorectal sporadic adenomatous polyps trials: stepping stones to progress.
    Hawk E; Viner JL
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):185-7. PubMed ID: 17301246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effective also in Bechterew disease].
    MMW Fortschr Med; 2007 Jun; 149(25-26):46-7. PubMed ID: 17713052
    [No Abstract]   [Full Text] [Related]  

  • 13. A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
    Sooriakumaran P; Coley HM; Fox SB; Macanas-Pirard P; Lovell DP; Henderson A; Eden CG; Miller PD; Langley SE; Laing RW
    Anticancer Res; 2009 May; 29(5):1483-8. PubMed ID: 19443354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Celecoxib-induced deep-vein thrombosis.
    Chan AL
    Ann Pharmacother; 2005 Jun; 39(6):1138. PubMed ID: 15840730
    [No Abstract]   [Full Text] [Related]  

  • 15. Celecoxib in the treatment of primary dysmenorrhea: results from two randomized, double-blind, active- and placebo-controlled, crossover studies.
    Daniels S; Robbins J; West CR; Nemeth MA
    Clin Ther; 2009 Jun; 31(6):1192-208. PubMed ID: 19695387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials. Halt of Celebrex study threatens drug's future, other trials.
    Couzin J
    Science; 2004 Dec; 306(5705):2170. PubMed ID: 15618492
    [No Abstract]   [Full Text] [Related]  

  • 17. Asthmatic reaction induced by celecoxib in a patient with aspirin-induced asthma.
    Muñoz-Cano R; Bartra J; Vennera MC; Valero A; Picado C
    J Investig Allergol Clin Immunol; 2009; 19(1):75-6. PubMed ID: 19274941
    [No Abstract]   [Full Text] [Related]  

  • 18. New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra).
    Cotter J; Wooltorton E
    CMAJ; 2005 May; 172(10):1299. PubMed ID: 15833921
    [No Abstract]   [Full Text] [Related]  

  • 19. Coxibs and cardiovascular risk.
    Allen MJ; McLean-Veysey P; Fleming I
    CMAJ; 2005 Oct; 173(8):853. PubMed ID: 16217098
    [No Abstract]   [Full Text] [Related]  

  • 20. Did targeted therapy fail cyclooxygenase too?
    Csiki I; Johnson DH
    J Clin Oncol; 2006 Oct; 24(30):4798-800. PubMed ID: 17050864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.